美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CervoMed

3.72

-0.2000-5.10%

盤後：3.720.00000.00%16:10 EDT

成交量：5.29萬

成交額：19.97萬

市值：3,442.01萬

市盈率：-1.25

高：4.00

開：3.90

低：3.68

收：3.92

52周最高：14.00

52周最低：3.58

股本：925.27萬

流通股本：493.43萬

量比：1.56

換手率：1.07%

股息：- -

股息率：- -

每股收益(TTM):-2.9824

每股收益(LYR):-2.9824

淨資產收益率：-93.92%

總資產收益率：-53.62%

市淨率：1.89

市盈率(LYR):-1.25

資料載入中...

總覽公司新聞資訊公告

BUZZ-CervoMed 因實驗性藥物在早期痴呆症患者中顯示出療效而上漲

CervoMed於2026年Ad/Pd™科學會議公布新數據，進一步證實Neflamapimod對無阿爾茨海默病共病理的路易體痴呆患者具有積極療效

CervoMed確定針對路易體痴呆症患者的三期臨床試驗配方及給藥方案

Cervomed Inc.盤中異動股價大漲5.14%

CervoMed旗下Neflamapimod獲選納入英國Experts-ALS平台，旨在優先推進肌萎縮側索硬化症的潛力療法

Cervomed Inc.盤中異動下午盤股價大跌5.17%報7.15美元

CervoMed將在第18屆阿爾茨海默病臨床試驗會議上分享Neflamapimod治療路易體痴呆的新數據

Cervomed Inc.盤中異動急速下跌6.68%報7.66美元

Cervomed Inc.盤中異動早盤股價大跌5.21%報6.91美元

Cervomed Inc.盤中異動大幅上漲5.56%報7.41美元

CervoMed公布與FDA就Neflamapimod在路易體痴呆註冊路徑達成一致

新聞稿：CervoMed通過任命生命科學商業戰略專家David Quigley強化董事會

Cervomed Inc.盤中異動急速跳水5.19%

嗡嗡聲--美國股票走勢-聯合租賃、戴爾、Datadog

BUZZ-痴呆症藥物在中期研究中顯示出前景後，CervoMed 公司業績上漲

CervoMed公布2B期臨床試驗新數據，顯示Neflamapimod治療路易體痴呆症的潛力

CervoMed任命Matthew Winton博士為首席商務和業務官

Cervomed Inc.盤中異動股價大漲6.36%報8.69美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CRVO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":3.72,"timestamp":1774641600000,"preClose":3.92,"halted":0,"volume":52900,"hourTrading":{"tag":"盘后","latestPrice":3.72,"preClose":3.72,"latestTime":"16:10 EDT","volume":7,"amount":26.04,"timestamp":1774642204781,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05102040816326524,"floatShares":4934300,"shares":9252719,"eps":-2.982424,"marketStatus":"已收盤","change":-0.2,"latestTime":"03-27 16:00:00 EDT","open":3.9,"high":4,"low":3.68,"amount":199666.3422,"amplitude":0.081633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.982424,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":3.92,"postHourTrading":{"tag":"盘后","latestPrice":3.72,"preClose":3.72,"latestTime":"16:10 EDT","volume":7,"amount":26.04,"timestamp":1774642204781,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.564746},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","floatShares":4934300,"roa":"-53.62%","roe":"-93.92%","lyrEps":-2.982424,"volumeRatio":1.564746,"shares":9252719,"dividePrice":0,"high":4,"amplitude":0.081633,"preClose":3.92,"low":3.68,"week52Low":3.58,"pbRate":"1.89","psRate":"8.59","week52High":14,"institutionHeld":0,"latestPrice":3.72,"eps":-2.982424,"divideRate":0,"volume":52900,"delay":0,"ttmEps":-2.982424,"open":3.9,"prevYearClose":7.9,"prevWeekClose":4.02,"prevMonthClose":3.99,"prevQuarterClose":7.9,"fiveDayClose":4.02,"twentyDayClose":3.99,"sixtyDayClose":7.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRVO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-13","symbol":"CRVO","fiscalQuarterEnding":"2025/12","expectedEps":-0.79,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-11-07","symbol":"CRVO","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-08-08","symbol":"CRVO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-05-12","symbol":"CRVO","fiscalQuarterEnding":"2025/03","expectedEps":-0.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2025-03-17","symbol":"CRVO","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":8,"updateTime":1766116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRVO","date":"2026-03-26","current":-1.247308,"percent":0.985938,"low":-119.682483,"twenty":-37.39506,"median":-5.035697,"eighty":-2.82005,"high":-1.31262,"avg":-19.225414,"sd":24.140611,"marketCap":37405224},"quantilePoints":[{"date":"2023-09-01","current":-5.788607,"twenty":-5.849231,"median":-5.813052,"eighty":-5.769051,"marketCap":33591560},{"date":"2023-09-08","current":-5.135433,"twenty":-5.817941,"median":-5.700604,"eighty":-4.975855,"marketCap":29801161},{"date":"2023-09-15","current":-4.791246,"twenty":-5.769051,"median":-5.182368,"eighty":-4.935961,"marketCap":27803825},{"date":"2023-09-22","current":-4.51746,"twenty":-5.708427,"median":-5.1589,"eighty":-4.822536,"marketCap":26215035},{"date":"2023-09-29","current":-4.66902,"twenty":-5.505043,"median":-5.045475,"eighty":-4.536234,"marketCap":27094543},{"date":"2023-10-06","current":-5.250814,"twenty":-5.262548,"median":-5.040586,"eighty":-4.536234,"marketCap":30470722},{"date":"2023-10-13","current":-6.893527,"twenty":-5.817941,"median":-5.065031,"eighty":-4.595684,"marketCap":40003462},{"date":"2023-10-20","current":-8.995809,"twenty":-6.690143,"median":-5.197035,"eighty":-4.691783,"marketCap":52203100},{"date":"2023-10-27","current":-9.201148,"twenty":-7.153624,"median":-5.22148,"eighty":-4.714546,"marketCap":53394692},{"date":"2023-11-03","current":-8.379791,"twenty":-8.309389,"median":-5.27037,"eighty":-4.77036,"marketCap":48628322},{"date":"2023-11-10","current":-9.709606,"twenty":-8.530373,"median":-5.764162,"eighty":-4.78929,"marketCap":56345302},{"date":"2023-11-17","current":-41.851906,"twenty":-9.287195,"median":-5.866832,"eighty":-4.791246,"marketCap":55950767},{"date":"2023-11-24","current":-43.761983,"twenty":-9.977525,"median":-6.385068,"eighty":-4.83818,"marketCap":58504301},{"date":"2023-12-01","current":-41.597229,"twenty":-22.855354,"median":-7.177091,"eighty":-4.969206,"marketCap":55610296},{"date":"2023-12-08","current":-37.39506,"twenty":-39.737313,"median":-7.68555,"eighty":-5.041564,"marketCap":49992521},{"date":"2023-12-15","current":-37.352614,"twenty":-39.16082,"median":-8.389569,"eighty":-5.054275,"marketCap":49935776},{"date":"2023-12-22","current":-28.736045,"twenty":-38.685423,"median":-8.477572,"eighty":-5.063075,"marketCap":38416500},{"date":"2023-12-29","current":-26.825968,"twenty":-38.401034,"median":-8.868694,"eighty":-5.079111,"marketCap":35862966},{"date":"2024-01-05","current":-39.899383,"twenty":-38.549596,"median":-9.044699,"eighty":-5.121353,"marketCap":53340488},{"date":"2024-01-12","current":-39.88198,"twenty":-39.488419,"median":-9.670494,"eighty":-5.172981,"marketCap":53317222},{"date":"2024-01-19","current":-38.625999,"twenty":-39.313626,"median":-10.04206,"eighty":-5.199968,"marketCap":51638132},{"date":"2024-01-26","current":-38.965567,"twenty":-39.313626,"median":-10.775414,"eighty":-5.223436,"marketCap":52092093},{"date":"2024-02-02","current":-34.593614,"twenty":-39.237223,"median":-27.727949,"eighty":-5.242992,"marketCap":46247338},{"date":"2024-02-09","current":-43.719537,"twenty":-39.237223,"median":-28.736045,"eighty":-5.262548,"marketCap":58447556},{"date":"2024-02-16","current":-68.677874,"twenty":-39.888941,"median":-31.961952,"eighty":-5.505043,"marketCap":91813733},{"date":"2024-02-23","current":-59.169936,"twenty":-40.466999,"median":-34.275268,"eighty":-5.692782,"marketCap":79102808},{"date":"2024-03-01","current":-63.372175,"twenty":-41.597229,"median":-35.401364,"eighty":-5.759273,"marketCap":84720676},{"date":"2024-03-08","current":-73.849585,"twenty":-41.945287,"median":-36.142899,"eighty":-5.808163,"marketCap":98727664},{"date":"2024-03-15","current":-76.245081,"twenty":-43.210183,"median":-36.501144,"eighty":-5.849231,"marketCap":101930142},{"date":"2024-03-22","current":-103.758666,"twenty":-50.901256,"median":-37.320992,"eighty":-6.027192,"marketCap":138712367},{"date":"2024-03-28","current":-90.558053,"twenty":-57.709789,"median":-37.373837,"eighty":-6.291199,"marketCap":121064797},{"date":"2024-04-05","current":-61.481111,"twenty":-59.566286,"median":-37.479952,"eighty":-6.48676,"marketCap":133529165},{"date":"2024-04-12","current":-71.595379,"twenty":-59.997513,"median":-38.212361,"eighty":-6.942417,"marketCap":155496070},{"date":"2024-04-19","current":-71.737433,"twenty":-62.930842,"median":-38.413768,"eighty":-7.153624,"marketCap":155804594},{"date":"2024-04-26","current":-94.969175,"twenty":-65.856384,"median":-38.647222,"eighty":-7.237715,"marketCap":206260987},{"date":"2024-05-03","current":-91.738931,"twenty":-67.584491,"median":-38.965567,"eighty":-7.396119,"marketCap":199245307},{"date":"2024-05-10","current":-90.826862,"twenty":-70.379394,"median":-39.220244,"eighty":-7.806798,"marketCap":197264409},{"date":"2024-05-17","current":-48.426621,"twenty":-71.185147,"median":-39.390029,"eighty":-8.309389,"marketCap":201061130},{"date":"2024-05-24","current":-37.632017,"twenty":-70.941929,"median":-39.252477,"eighty":-8.383702,"marketCap":156243317},{"date":"2024-05-31","current":-37.651896,"twenty":-70.600999,"median":-39.231253,"eighty":-8.399347,"marketCap":156325854},{"date":"2024-06-07","current":-38.148885,"twenty":-69.492975,"median":-39.142864,"eighty":-8.458016,"marketCap":158389289},{"date":"2024-06-14","current":-37.791053,"twenty":-68.677874,"median":-39.132924,"eighty":-8.477572,"marketCap":156903616},{"date":"2024-06-21","current":-39.600094,"twenty":-68.284435,"median":-39.132924,"eighty":-8.688778,"marketCap":164414520},{"date":"2024-06-28","current":-34.033815,"twenty":-67.93606,"median":-39.122984,"eighty":-8.944963,"marketCap":141304045},{"date":"2024-07-05","current":-30.813326,"twenty":-67.00636,"median":-39.083225,"eighty":-9.025143,"marketCap":127932985},{"date":"2024-07-12","current":-31.707906,"twenty":-66.374913,"median":-38.90211,"eighty":-9.138568,"marketCap":131647168},{"date":"2024-07-19","current":-32.304293,"twenty":-66.254136,"median":-38.668445,"eighty":-9.459288,"marketCap":134123291},{"date":"2024-07-26","current":-27.89103,"twenty":-66.009803,"median":-38.625997,"eighty":-9.678316,"marketCap":115799986},{"date":"2024-08-02","current":-21.131978,"twenty":-65.799563,"median":-38.413768,"eighty":-9.715473,"marketCap":87737266},{"date":"2024-08-09","current":-18.460659,"twenty":-64.992694,"median":-38.255401,"eighty":-10.106595,"marketCap":93102198},{"date":"2024-08-16","current":-29.88401,"twenty":-63.82037,"median":-38.148885,"eighty":-10.558342,"marketCap":150713310},{"date":"2024-08-23","current":-26.709039,"twenty":-63.123956,"median":-37.878225,"eighty":-10.740213,"marketCap":134701053},{"date":"2024-08-30","current":-30.47318,"twenty":-62.875574,"median":-37.791053,"eighty":-10.88395,"marketCap":153684657},{"date":"2024-09-06","current":-23.484969,"twenty":-62.310952,"median":-37.632017,"eighty":-13.958048,"marketCap":118441183},{"date":"2024-09-13","current":-28.656572,"twenty":-61.520597,"median":-37.39506,"eighty":-19.017097,"marketCap":144523004},{"date":"2024-09-20","current":-27.560062,"twenty":-60.889782,"median":-37.352614,"eighty":-20.363844,"marketCap":138992998},{"date":"2024-09-27","current":-24.761504,"twenty":-59.992238,"median":-37.044217,"eighty":-21.696558,"marketCap":124879101},{"date":"2024-10-04","current":-23.484969,"twenty":-59.885067,"median":-36.618159,"eighty":-21.737099,"marketCap":118441183},{"date":"2024-10-11","current":-22.093874,"twenty":-59.702244,"median":-36.256014,"eighty":-21.195966,"marketCap":111425503},{"date":"2024-10-18","current":-23.40314,"twenty":-59.499033,"median":-36.121676,"eighty":-21.422875,"marketCap":118028496},{"date":"2024-10-25","current":-22.42119,"twenty":-59.246339,"median":-35.506843,"eighty":-21.041389,"marketCap":113076251},{"date":"2024-11-01","current":-20.964631,"twenty":-58.949205,"median":-34.593614,"eighty":-21.041389,"marketCap":105730422},{"date":"2024-11-08","current":-20.522754,"twenty":-58.467774,"median":-33.995368,"eighty":-20.604583,"marketCap":103501912},{"date":"2024-11-15","current":-7.440484,"twenty":-58.205855,"median":-32.960319,"eighty":-20.319817,"marketCap":88892790},{"date":"2024-11-22","current":-6.632186,"twenty":-57.268349,"median":-31.876883,"eighty":-19.75356,"marketCap":79235913},{"date":"2024-11-29","current":-7.461209,"twenty":-55.646905,"median":-31.638328,"eighty":-10.811593,"marketCap":89140402},{"date":"2024-12-06","current":-8.228056,"twenty":-54.314096,"median":-31.509111,"eighty":-9.711562,"marketCap":98302055},{"date":"2024-12-13","current":-1.31262,"twenty":-52.81792,"median":-30.753634,"eighty":-9.005587,"marketCap":15682107},{"date":"2024-12-20","current":-1.540602,"twenty":-48.999152,"median":-30.455494,"eighty":-8.411081,"marketCap":18405842},{"date":"2024-12-27","current":-1.658046,"twenty":-48.426621,"median":-29.978384,"eighty":-8.228056,"marketCap":19808978},{"date":"2025-01-03","current":-1.609687,"twenty":-47.997222,"median":-29.785815,"eighty":-7.657262,"marketCap":19231216},{"date":"2025-01-10","current":-1.457699,"twenty":-47.144687,"median":-29.245398,"eighty":-7.393795,"marketCap":17415393},{"date":"2025-01-17","current":-1.457699,"twenty":-44.916349,"median":-28.653863,"eighty":-7.183487,"marketCap":17415393},{"date":"2025-01-24","current":-1.59587,"twenty":-43.761983,"median":-28.638191,"eighty":-7.010773,"marketCap":19066141},{"date":"2025-01-31","current":-1.561327,"twenty":-43.745005,"median":-28.566935,"eighty":-6.6764,"marketCap":18653454},{"date":"2025-02-07","current":-1.526784,"twenty":-43.24863,"median":-27.889204,"eighty":-6.348881,"marketCap":18240767},{"date":"2025-02-14","current":-1.609687,"twenty":-42.503822,"median":-27.789183,"eighty":-5.849231,"marketCap":19231216},{"date":"2025-02-21","current":-1.575144,"twenty":-42.386727,"median":-27.612716,"eighty":-5.677137,"marketCap":18818529},{"date":"2025-02-28","current":-1.54751,"twenty":-42.123561,"median":-27.159099,"eighty":-5.235169,"marketCap":18488379},{"date":"2025-03-07","current":-1.526784,"twenty":-42.013202,"median":-26.709039,"eighty":-5.079111,"marketCap":18240767},{"date":"2025-03-14","current":-4.449091,"twenty":-41.962266,"median":-26.52242,"eighty":-4.902715,"marketCap":53154092},{"date":"2025-03-21","current":-7.633919,"twenty":-41.885863,"median":-26.463551,"eighty":-4.893488,"marketCap":124361854},{"date":"2025-03-28","current":-5.06435,"twenty":-41.817949,"median":-26.005308,"eighty":-4.799924,"marketCap":82501776},{"date":"2025-04-04","current":-5.919092,"twenty":-41.665143,"median":-25.710723,"eighty":-4.841604,"marketCap":96426126},{"date":"2025-04-11","current":-4.538149,"twenty":-41.597229,"median":-25.473418,"eighty":-4.783424,"marketCap":73929597},{"date":"2025-04-17","current":-5.235298,"twenty":-41.597229,"median":-25.219748,"eighty":-4.791246,"marketCap":85286646},{"date":"2025-04-25","current":-4.61561,"twenty":-41.512337,"median":-24.761504,"eighty":-4.727795,"marketCap":75191492},{"date":"2025-05-02","current":-5.475694,"twenty":-41.298141,"median":-24.40964,"eighty":-4.781468,"marketCap":89202869},{"date":"2025-05-09","current":-4.535478,"twenty":-40.703923,"median":-23.894115,"eighty":-4.754506,"marketCap":73886084},{"date":"2025-05-16","current":-4.092569,"twenty":-40.111614,"median":-23.509518,"eighty":-4.701084,"marketCap":76409872},{"date":"2025-05-23","current":-3.924764,"twenty":-39.899383,"median":-23.40314,"eighty":-4.546794,"marketCap":73276893},{"date":"2025-05-30","current":-3.631106,"twenty":-39.899383,"median":-22.993995,"eighty":-4.534221,"marketCap":67794181},{"date":"2025-06-06","current":-3.514575,"twenty":-39.885461,"median":-22.735979,"eighty":-4.503786,"marketCap":65618501},{"date":"2025-06-13","current":-3.551865,"twenty":-39.7837,"median":-22.503019,"eighty":-4.258784,"marketCap":66314718},{"date":"2025-06-20","current":-3.258207,"twenty":-39.75913,"median":-22.404825,"eighty":-4.158521,"marketCap":60832005},{"date":"2025-06-27","current":-3.311811,"twenty":-39.663708,"median":-22.077508,"eighty":-4.077653,"marketCap":61832818},{"date":"2025-07-03","current":-2.633601,"twenty":-39.550025,"median":-21.823837,"eighty":-3.980044,"marketCap":49170362},{"date":"2025-07-11","current":-3.360754,"twenty":-39.440965,"median":-21.455606,"eighty":-3.896797,"marketCap":62746603},{"date":"2025-07-18","current":-3.528559,"twenty":-39.386585,"median":-21.072854,"eighty":-3.646022,"marketCap":65879582},{"date":"2025-07-25","current":-3.752298,"twenty":-39.349611,"median":-20.964631,"eighty":-3.646022,"marketCap":70056887},{"date":"2025-08-01","current":-3.845523,"twenty":-39.3019,"median":-20.547303,"eighty":-3.685176,"marketCap":71797431},{"date":"2025-08-08","current":-4.353598,"twenty":-39.293948,"median":-20.408193,"eighty":-3.727127,"marketCap":81283395},{"date":"2025-08-15","current":-4.169718,"twenty":-39.274289,"median":-19.933584,"eighty":-3.76778,"marketCap":94285206},{"date":"2025-08-22","current":-3.772796,"twenty":-39.254519,"median":-19.688096,"eighty":-3.760497,"marketCap":85310069},{"date":"2025-08-29","current":-3.813716,"twenty":-39.233455,"median":-10.865861,"eighty":-3.760497,"marketCap":86235341},{"date":"2025-09-05","current":-4.177901,"twenty":-39.220244,"median":-10.526074,"eighty":-3.773614,"marketCap":94470260},{"date":"2025-09-12","current":-3.764612,"twenty":-39.204768,"median":-9.709606,"eighty":-3.773614,"marketCap":85125014},{"date":"2025-09-19","current":-3.314496,"twenty":-39.138888,"median":-9.122923,"eighty":-3.737606,"marketCap":74947023},{"date":"2025-09-26","current":-3.199921,"twenty":-39.116968,"median":-8.741579,"eighty":-3.623336,"marketCap":72356262},{"date":"2025-10-03","current":-3.34314,"twenty":-39.09097,"median":-8.428681,"eighty":-3.551865,"marketCap":75594714},{"date":"2025-10-10","current":-3.494542,"twenty":-39.075273,"median":-8.291789,"eighty":-3.534152,"marketCap":79018220},{"date":"2025-10-17","current":-3.109897,"twenty":-39.027886,"median":-7.962078,"eighty":-3.498549,"marketCap":70320664},{"date":"2025-10-24","current":-2.897115,"twenty":-38.940184,"median":-7.633919,"eighty":-3.482878,"marketCap":65509250},{"date":"2025-10-31","current":-2.909391,"twenty":-38.804612,"median":-7.450846,"eighty":-3.374238,"marketCap":65786832},{"date":"2025-11-07","current":-2.983046,"twenty":-38.663931,"median":-7.254628,"eighty":-3.361323,"marketCap":67452321},{"date":"2025-11-14","current":-2.621936,"twenty":-38.6419,"median":-7.20399,"eighty":-3.333221,"marketCap":67082212},{"date":"2025-11-21","current":-3.258434,"twenty":-38.625998,"median":-7.137979,"eighty":-3.315314,"marketCap":83366998},{"date":"2025-11-28","current":-3.594765,"twenty":-38.625995,"median":-6.963795,"eighty":-3.314496,"marketCap":91972026},{"date":"2025-12-05","current":-3.276516,"twenty":-38.456214,"median":-6.708179,"eighty":-3.314142,"marketCap":83829634},{"date":"2025-12-12","current":-2.961884,"twenty":-38.413768,"median":-6.632186,"eighty":-3.290836,"marketCap":75779768},{"date":"2025-12-19","current":-2.857006,"twenty":-38.350099,"median":-6.354912,"eighty":-3.258434,"marketCap":73096480},{"date":"2025-12-26","current":-3.066761,"twenty":-38.300453,"median":-6.221623,"eighty":-3.198527,"marketCap":78463057},{"date":"2026-01-02","current":-2.857006,"twenty":-38.248873,"median":-6.028218,"eighty":-3.184173,"marketCap":73096480},{"date":"2026-01-09","current":-2.846157,"twenty":-38.210281,"median":-5.866832,"eighty":-3.139814,"marketCap":72818898},{"date":"2026-01-16","current":-2.560456,"twenty":-38.170115,"median":-5.764162,"eighty":-3.103963,"marketCap":65509250},{"date":"2026-01-23","current":-2.379633,"twenty":-38.109126,"median":-5.691463,"eighty":-3.066761,"marketCap":60882891},{"date":"2026-01-30","current":-1.869712,"twenty":-37.999948,"median":-5.513005,"eighty":-3.019747,"marketCap":47836557},{"date":"2026-02-06","current":-1.663573,"twenty":-37.887707,"median":-5.323443,"eighty":-2.9876,"marketCap":42562507},{"date":"2026-02-13","current":-1.638258,"twenty":-37.814908,"median":-5.250814,"eighty":-2.957395,"marketCap":41914817},{"date":"2026-02-20","current":-1.89141,"twenty":-37.791053,"median":-5.231258,"eighty":-2.930623,"marketCap":48391720},{"date":"2026-02-27","current":-1.591244,"twenty":-37.763222,"median":-5.212816,"eighty":-2.89957,"marketCap":40711963},{"date":"2026-03-06","current":-1.450202,"twenty":-37.64792,"median":-5.171192,"eighty":-2.886661,"marketCap":37103403},{"date":"2026-03-13","current":-1.565929,"twenty":-37.601604,"median":-5.067362,"eighty":-2.872563,"marketCap":40064273},{"date":"2026-03-20","current":-1.452342,"twenty":-37.462974,"median":-5.060142,"eighty":-2.848327,"marketCap":39164381},{"date":"2026-03-26","current":-1.387107,"twenty":-37.39506,"median":-5.035697,"eighty":-2.82005,"marketCap":37405224}],"updateTime":1774666750147},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRVO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620263228","title":"BUZZ-CervoMed 因實驗性藥物在早期痴呆症患者中顯示出療效而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2620263228","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620263228?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 20:46","pubTimestamp":1773924375,"startTime":"0","endTime":"0","summary":"BUZZ-CervoMed 因实验性药物在早期痴呆症患者中显示出疗效而上涨3月19日 - ** 生物技术公司CervoMed CRVO.O股价上涨8%至4.58美元** 该公司称，新的试验分析表明，其试验性药物neflamapimod对早期路易体痴呆症患者的疗效最佳，路易体痴呆症是一种影响记忆、思维和运动的脑部疾病 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL4S4071F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1190106082","title":"CervoMed於2026年Ad/Pd™科學會議公布新數據，進一步證實Neflamapimod對無阿爾茨海默病共病理的路易體痴呆患者具有積極療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190106082?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据，这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势，为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1186895438","title":"CervoMed確定針對路易體痴呆症患者的三期臨床試驗配方及給藥方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186895438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186895438?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 20:32","pubTimestamp":1772627574,"startTime":"0","endTime":"0","summary":"CervoMed已正式确定其针对路易体痴呆症患者的三期临床试验的最终配方及给药方案。这一关键决策标志着该公司在推进神经退行性疾病治疗研究方面迈出了重要一步，为后续临床试验的开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2616287587","title":"Cervomed Inc.盤中異動 股價大漲5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616287587?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 03:07","pubTimestamp":1772564827,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时07分，Cervomed Inc.股票出现异动，股价快速上涨5.14%。截至发稿，该股报4.09美元/股，成交量5.2395万股，换手率0.57%，振幅7.67%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Calcimedica, Inc.涨幅较大，Edesa Biotech, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为296.56%、138.89%、128.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.36%、43.99%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1173716197","title":"CervoMed旗下Neflamapimod獲選納入英國Experts-ALS平台，旨在優先推進肌萎縮側索硬化症的潛力療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1173716197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173716197?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 19:02","pubTimestamp":1771412559,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，其研发的候选药物Neflamapimod已被遴选加入英国Experts-ALS平台。该平台的核心目标在于识别并优先推进针对肌萎缩侧索硬化症（ALS）最具前景的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2603621395","title":"Cervomed Inc.盤中異動 下午盤股價大跌5.17%報7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603621395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603621395?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 04:08","pubTimestamp":1768421338,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日04时08分，Cervomed Inc.股票出现波动，股价大幅下跌5.17%。截至发稿，该股报7.15美元/股，成交量4.623万股，换手率0.50%，振幅3.51%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115040859a4c46e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1126237005","title":"CervoMed將在第18屆阿爾茨海默病臨床試驗會議上分享Neflamapimod治療路易體痴呆的新數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1126237005","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126237005?lang=zh_tw&edition=fundamental","pubTime":"2025-11-24 20:02","pubTimestamp":1763985767,"startTime":"0","endTime":"0","summary":"CervoMed将在第18届阿尔茨海默病临床试验会议上分享Neflamapimod治疗路易体痴呆的新数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2584917508","title":"Cervomed Inc.盤中異動 急速下跌6.68%報7.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584917508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584917508?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 22:31","pubTimestamp":1763476294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时31分，Cervomed Inc.股票出现异动，股价大幅跳水6.68%。截至发稿，该股报7.66美元/股，成交量6829股，换手率0.07%，振幅2.07%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Clearmind Medicine Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为941.48%、452.82%、265.25%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为27.23%、16.40%、14.20%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223135950c6452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2581783100","title":"Cervomed Inc.盤中異動 早盤股價大跌5.21%報6.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783100?lang=zh_tw&edition=fundamental","pubTime":"2025-11-08 00:16","pubTimestamp":1762532193,"startTime":"0","endTime":"0","summary":"北京时间2025年11月08日00时16分，Cervomed Inc.股票出现波动，股价快速下跌5.21%。截至发稿，该股报6.91美元/股，成交量1.6724万股，换手率0.18%，振幅4.73%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Puma Biotechnology Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Metavia Inc.、Tharimmune, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为157.35%、71.84%、28.33%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为70.00%、37.11%、33.73%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108001634a6e92dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2581740156","title":"Cervomed Inc.盤中異動 大幅上漲5.56%報7.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581740156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581740156?lang=zh_tw&edition=fundamental","pubTime":"2025-11-04 22:56","pubTimestamp":1762268171,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时56分，Cervomed Inc.股票出现异动，股价大幅上涨5.56%。截至发稿，该股报7.41美元/股，成交量2.6815万股，换手率0.29%，振幅4.20%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃，换手率分别为278.07%、97.30%、67.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Terns Pharmaceuticals, Inc.、Nuvation Bio Inc.，振幅分别为36.13%、23.09%、22.63%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511042256119753ab53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1166172288","title":"CervoMed公布與FDA就Neflamapimod在路易體痴呆註冊路徑達成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1166172288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166172288?lang=zh_tw&edition=fundamental","pubTime":"2025-11-04 20:03","pubTimestamp":1762257793,"startTime":"0","endTime":"0","summary":"CervoMed公布与FDA就Neflamapimod在路易体痴呆注册路径达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1180758735","title":"新聞稿：CervoMed通過任命生命科學商業戰略專家David Quigley強化董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1180758735","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180758735?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 20:05","pubTimestamp":1761653141,"startTime":"0","endTime":"0","summary":"David Quigley先生最近担任麦肯锡公司的私人资本业务领导，并曾在该公司领导多个生命科学实践团队。此次任命为CervoMed在准备第三阶段临床试验和商业化计划时增添了丰富的商业战略、交易和商业专业知识。波士顿，2025年10月28日——CervoMed Inc.是一家正在开发与年龄相关的脑部疾病治疗方案的临床阶段生物技术公司，今天宣布David Quigley被任命为其董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","DLB","LU0205193047.USD","CRVO","LU0240877869.USD","LU0345774391.USD","LU0345774631.USD","BK4139","LU0240878834.USD","LU0348723411.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"2577383770","title":"Cervomed Inc.盤中異動 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577383770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577383770?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 01:22","pubTimestamp":1761067337,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日01时22分，Cervomed Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.12美元/股，成交量5.0418万股，换手率0.54%，振幅4.32%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Minerva Neurosciences, Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为2139.14%、273.87%、197.89%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为215.34%、100.00%、67.96%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022012217a46cc1ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2573927059","title":"嗡嗡聲--美國股票走勢-聯合租賃、戴爾、Datadog","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927059","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573927059?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 23:43","pubTimestamp":1759938189,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.30%，报46,740.90点。标准普尔500指数.SPX上涨0.52%，报6749.45点；纳斯达克综合指数.IXIC上涨0.77%，报22964.05点。nL3N3VP0QB ** Elf Beauty Inc < ELF.N  >:BUZZ - 因摩根士丹利以 Rhode 护肤品业绩为由上调 PT 值而上涨   nL6N3VP0MZ ** Equifa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nL3T3VP0ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOTH","HL","LU0154245673.USD","LU0053671581.USD","CFLT","CVS","LU1242518857.USD","IE0002270589.USD","BK4123","FRPT","LU0788108826.HKD","LU2498475776.HKD","NEXT","CDE","CAT","JEF","LU0122376428.USD","LYV","SCCO","LU2211817866.USD","ARCB","EFX","LU0300736492.USD","DDOG","LU0498741890.SGD","FDX","DELL","F","LU0433182093.SGD","NEM","URI","ELF","SMTC","CMI","CTVA","CRVO","WERN","SLB","ZBIO","LU0310800965.SGD","PSX","HOWL","BLD"],"gpt_icon":1},{"id":"2573285779","title":"BUZZ-痴呆症藥物在中期研究中顯示出前景後，CervoMed 公司業績上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2573285779","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573285779?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 19:55","pubTimestamp":1759924558,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nL3T3VP0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"1172856980","title":"CervoMed公布2B期臨床試驗新數據，顯示Neflamapimod治療路易體痴呆症的潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1172856980","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172856980?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 19:00","pubTimestamp":1759921226,"startTime":"0","endTime":"0","summary":"CervoMed公布2B期临床试验新数据，显示Neflamapimod治疗路易体痴呆症的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"1136915279","title":"CervoMed任命Matthew Winton博士為首席商務和業務官","url":"https://stock-news.laohu8.com/highlight/detail?id=1136915279","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136915279?lang=zh_tw&edition=fundamental","pubTime":"2025-10-07 20:05","pubTimestamp":1759838740,"startTime":"0","endTime":"0","summary":"波士顿，2025年10月7日 —— CervoMed Inc.是一家专注于开发年龄相关神经系统疾病治疗方法的临床阶段公司，今日宣布任命Matthew Winton博士为首席商务和业务官。Winton博士拥有近二十年的全球生物技术行业经验，在领导组织实现科学突破、发展创新和市场转型方面表现卓越。CervoMed首席执行官John Alam医学博士表示：\"很高兴欢迎Matthew这位经验丰富且经过验证的领导者和组织建设者。这一任命正值CervoMed进入后期第三阶段开发的关键时刻。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4555","LU0205194284.USD","BK4097","BK4217","BK4139","03160","LU0348723411.USD","BK4604","LU0345774391.USD","BK4099","DLB","LU0240878834.USD","LU0240877869.USD","LU0345774631.USD","LU0205193047.USD","BK4585","SMA","CRVO","TM"],"gpt_icon":0},{"id":"2572570436","title":"Cervomed Inc.盤中異動 股價大漲6.36%報8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572570436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572570436?lang=zh_tw&edition=fundamental","pubTime":"2025-10-03 21:51","pubTimestamp":1759499472,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时51分，Cervomed Inc.股票出现异动，股价大幅拉升6.36%。截至发稿，该股报8.69美元/股，成交量2.1024万股，换手率0.24%，振幅4.32%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Alto Neuroscience, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Palisade Bio, Inc.、Ovid Therapeutics Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为55.71%、48.44%、43.69%，振幅较大的相关个股有Alto Neuroscience, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Neurogene Inc.，振幅分别为32.88%、23.50%、17.59%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003215112a6ac30ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003215112a6ac30ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}